Neurology

Breast Cancer

Questions discussed in this category

How would you manage a patient who develops acute stroke during neoadjuvant chemotherapy with KEYNOTE-522 for Stage III triple negative breast cancer?

Would you continue KEYNOTE-522 neoadjuvant therapy? The patient has a PMH of sarcoidosis with no stroke risk factors. No residual deficits.

1 Answer available

What is your strategy to help prevent paclitaxel-related neuropathy?

Do you prophylactically start all patients on B12, B-complex, and/or omega-3? If so, what dose? What about ice mittens and booties?

3 Answers available

How do you manage neuropathic chemotherapy agents in patients with underlying multiple sclerosis?

Are there contraindications to drugs like oxaliplatin or abraxane? Does chronicity or severity of the patient's underlying symptoms play a role in yo...

1 Answer available

How do you modify TNBC neoadjuvant chemotherapy in patients with multiple sclerosis?

1 Answer available

How would you manage adjuvant endocrine therapy for a postmenopausal patient with early stage HR+ breast CA who develops an ischemic CVA on an AI?

Presuming that work-up for cardioembolic sources is negative, how would you proceed?

1 Answer available

Papers discussed in this category

Circulation, 2020 Feb 17

Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.

N. Engl. J. Med.,

Pembrolizumab for Early Triple-Negative Breast Cancer.

J Clin Oncol, 2020 Jul 14

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-06-20

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

J Clin Oncol, 2019 Dec 19

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).

Ann Oncol,

Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?

PloS one, 2017

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.

Circulation, 2016-03-29

Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991 Feb

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

Journal of stroke, 2020 Jan 31

Neurology

Breast Cancer

Questions discussed in this category

Papers discussed in this category

Related Topics in Neurology